AmpliPhi Biosciences Corp (49)

Browse by Contract Category

Contracts

Secured Convertible Credit and Security Agreement, dated January 10, 2023 (Filed With SEC on January 10, 2023)
Letter Agreement, dated December 14, 2022, by and between Armata Pharmaceuticals, Inc. and Todd R. Patrick (Filed With SEC on December 19, 2022)
Employment Agreement, dated March 28, 2022, between the Company and Ms. Butler (Filed With SEC on March 28, 2022)
Advisory Agreement, dated March 28, 2022, between the Company and Mr. Martin (Filed With SEC on March 28, 2022)
Lease Agreement, dated October 28, 2021, by and between Armata Pharmaceuticals, Inc. and 5005 McConnell Avenue, LLC (Filed With SEC on November 2, 2021)
Amendment, dated March 25, 2019, to Agreement and Plan of Merger and Reorganization, dated January 3, 2019, by and among the Company, C3J Therapeutics and Merger Sub (Filed With SEC on March 25, 2019)
Description of the Companys securities registered under Section 12 of the Exchange Act (Filed With SEC on March 17, 2022)
Amended and Restated Voting Agreement, dated February 9, 2022 by and between the Company, Innoviva, Inc. and Innoviva (Filed With SEC on February 11, 2022)
Registration Rights Agreement, dated February 9, 2022, by and between the Company and Innoviva (Filed With SEC on February 11, 2022)
Second Amended and Restated Investors Rights Agreement, dated February 9, 2022, by and among the Company, Innoviva, Inc. and Innoviva (Filed With SEC on February 11, 2022)
Securities Purchase Agreement, dated February 9, 2022, by and between the Company and Innoviva (Filed With SEC on February 11, 2022)
Form of Common Stock Warrant (Filed With SEC on February 11, 2022)
Securities Purchase Agreement, dated October 28, 2021, by and among the Company, Innoviva and CFF (Filed With SEC on October 29, 2021)
Amended and Restated Voting Agreement, dated October 28, 2021, by and among the Company, Innoviva and Innoviva, Inc (Filed With SEC on October 29, 2021)
Registration Rights Agreement, dated October 28, 2021, by and among the Company, Innoviva and CFF (Filed With SEC on October 29, 2021)
Amended Employment Agreement, dated August 9, 2021 between Armata Pharmaceuticals, Inc. and Todd Patrick (Filed With SEC on August 12, 2021)
Employment Agreement, dated August 1, 2021, between Armata Pharmaceuticals, Inc. and Brian Varnum, Ph.D (Filed With SEC on August 12, 2021)
Description of the Companys securities registered under Section 12 of the Exchange Act (Filed With SEC on March 18, 2021)
Form of Voting Agreement, by and between the Company and Innoviva (Filed With SEC on January 27, 2021)
Form of Registration Rights Agreement, by and between the Company and Innoviva (Filed With SEC on January 27, 2021)
Form of Amended and Restated Investors Rights Agreement, by and among the Company and Innoviva (Filed With SEC on January 27, 2021)
Securities Purchase Agreement, dated January 26, 2021, by and between the Company and Innoviva (Filed With SEC on January 27, 2021)
Form of Common Stock Warrant (Filed With SEC on January 27, 2021)
Employment Agreement, dated as of January 18, 2012, by and between C3 Jian, Inc. and Brian Varnum (Filed With SEC on May 14, 2020)
Assignment and First Amendment of Office Lease, dated as of April 2020, by and among Armata Pharmaceuticals, Inc., C3 Jian, Inc. and Marina Business Center, LLC (Filed With SEC on May 14, 2020)
Letter Agreement, dated as of March 10, 2020, by and between Armata Pharmaceuticals, Inc. and the Cystic Fibrosis Foundation (Filed With SEC on May 14, 2020)
Description of the Companys securities registered under Section 12 of the Exchange Act (Filed With SEC on March 19, 2020)
Investor Rights Agreement, dated February 12, 2020, by and between the Company and Innoviva (Filed With SEC on February 13, 2020)
Registration Rights Agreement, dated February 12, 2020, by and between the Company and Innoviva (Filed With SEC on February 13, 2020)
Form of Voting Agreement, to be entered into by and between Innoviva and certain stockholders of the Company (Filed With SEC on January 29, 2020)
Form of Investor Rights Agreement, by and the Company and Innoviva (Filed With SEC on January 29, 2020)
Securities Purchase Agreement, dated January 27, 2020, by and between the Company and Innoviva (Filed With SEC on January 29, 2020)
Form of Common Stock Warrant (Filed With SEC on January 29, 2020)
Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the Armata Pharmaceuticals, Inc. 2016 Equity Incentive Plan (Filed With SEC on August 14, 2019)
Asset Purchase Agreement, dated as of February 14, 2018, by and between C3J Therapeutics, Inc., Synthetic Genomics, Inc. and Synthetic Genomics Vaccines, Inc., as amended by... (Filed With SEC on August 14, 2019)
Armata Pharmaceuticals, Inc. 2016 Employee Stock Purchase Plan (Filed With SEC on August 14, 2019)
Research Collaboration and Option to License Agreement, effective as of May 24, 2017, by and between Synthetic Genomics, Inc. and Merck Sharp & Dohme Corp (Filed With SEC on August 14, 2019)
Registration Rights Agreement, dated as of May 9, 2019, by and among Armata Pharmaceuticals, Inc. and the Investors (Filed With SEC on May 10, 2019)
Form of the Armata Pharmaceuticals, Inc. Common Stock Certificate (Filed With SEC on May 10, 2019)
Form of Director Appointment Letter (Filed With SEC on May 10, 2019)
Amendment to Employment Agreement, dated as of January 16, 2019, between C3J Therapeutics, Inc. and Todd R. Patrick (Filed With SEC on May 10, 2019)
Employment Agreement, dated October 1, 2018, between C3J Therapeutics, Inc. and Todd R. Patrick (Filed With SEC on May 10, 2019)
Engagement letter agreement, dated December 13, 2017, as amended on December 17, 2018, by and between the Company and Ladenburg Thalmann & Co. Inc (Filed With SEC on March 25, 2019)
Form of Share Purchase Agreement by and among AmpliPhi Biosciences Corporation, C3J Therapeutics, Inc. and certain shareholders of C3J Therapeutics, Inc., dated as of February 5,... (Filed With SEC on February 7, 2019)
Agreement and Plan of Merger and Reorganization, dated January 3, 2019, by and among the Company, C3J Therapeutics and Merger Sub (Filed With SEC on January 4, 2019)
Form of C3J Lock-Up Agreement, dated January 3, 2019, by each of the parties named in each agreement therein (Filed With SEC on January 4, 2019)
Form of Company Lock-Up Agreement, dated January 3, 2019, by each of the parties named in each agreement therein (Filed With SEC on January 4, 2019)
Form of C3J Therapeutics Support Agreement, dated January 3, 2019, by and between the Company and each of the parties named in each agreement therein (Filed With SEC on January 4, 2019)
Form of Company Support Agreement, dated January 3, 2019, by and between C3J Therapeutics and each of the parties named in each agreement therein (Filed With SEC on January 4, 2019)